ViroVentures
Operations :: Hans Bunschoten, Ph.D.

Hans Bunschoten, Ph.D.


ViroClinics

Hans Bunschoten Ph.D.
Hans Bunschoten is Chief Operating Officer at ViroClinics. He is responsible for day to day management of ViroClinics’s operations.

He started his pharmaceutical career at a Dutch pharmaceutical company where he headed multidisciplinary teams in vaccine and drug discovery research. Subsequently, he worked as a Director of Preclinical Development at a pharmaceutical start-up company and as a management consultant advising pharmaceutical companies in distinct areas of drug development. Hans was trained in immunology and virology at the National Institute of Public Health and University of Pennsylvania and obtained a PhD from the University of Utrecht.

Members

Virus discovery to identify new
vaccine and diagnostic targets

Development of diagnostics and
treatments for hMPV

Diagnostic services and
contract research
News
CoroNovative BV to use Viroscope as a new tradename
Rotterdam, the Netherlands, Nov.8, 2006 - CoroNovative BV has announced that it will use Viroscope as a new tradename.
The use of this new tradename ...

CoroNovative and Nobilon join forces in virus discovery program
Rotterdam, the Netherlands, June 14, 2006 - CoroNovative BV to expand and accelerate its virus discovery program with the help of Akzo Nobel's Nobilon...
Launch of ViroVentures
Rotterdam, the Netherlands, July 1st, 2006 - ViroClinics BV, ViroNovative BV and Viroscope launch ViroVentures, a virtual organization in which the bu...